Results 41 to 50 of about 6,115,227 (208)

The novel CXCR4 antagonist POL5551 mobilizes hematopoietic stem and progenitor cells with greater efficiency than Plerixafor [PDF]

, 2013
Mobilized blood has supplanted bone marrow (BM) as the primary source of hematopoietic stem cells for autologous and allogeneic stem cell transplantation.
Dembowsky, K., Dembowsky, Klaus, Romagnoli, B., G Spohn, Karpova, Darja, Patel, K., Chevalier, E., Levesque, J. P., E Chevalier, D Karpova, Patel, Kalpana, Spohn, Gabriele, Romagnoli, Barbara, Schulz, M., Wiercinska, Eliza, Chevalier, Eric, H Bonig, K Dauber, E Wiercinska, J P Levesque, Schulz, Miriam, Chudziak, D., K Dembowsky, Dauber, Katrin, Karpova, D., B Romagnoli, A R Pettit, Wiercinska, E., D Chudziak, Levesque, Jean-Pierre, Bönig, Halvard-Björn, Spohn, G., Pettit, Allison R., M Schulz, K Patel, Bonig, H., Pettit, A. R., Chudziak, Doreen, Dauber, K.   +38 more
core   +1 more source

Haematopoietic cell transplantation in Switzerland, changes and results over 20 years: a report from the Swiss Blood Stem Cell Transplantation Working Group for Blood and Marrow Transplantation registry 1997-2016 [PDF]

, 2018
In 1997, the Swiss Blood Stem Cell Transplantation Group (SBST) initiated a mandatory national registry for all haematopoietic stem cell transplants (HCTs) in Switzerland.
Bargetzi, M., Kurt Leibundgut, Passweg, J.R., Renner, Christoph, Chalandon, Yves, Leibundgut, K., Leibundgut, Kurt, Grazia Nicoloso de Faveri, Swiss Blood Stem Cell Transplantation Group, SBST, Thomas Pabst, Christoph Renner, Duchosal, M.A., Baerlocher, Gabriela M, Nair, Gayathri, Ansari, M., Renner, C., Passweg, Jakob R, Sabine Gerull, Hess-Kappas, Ursula, Schanz, U., Schmidt, Adrian, Jakob R. Passweg, Gerull, S., Adrian Schmidt, Pabst, Thomas, Tayfun Güngör, Yves Chalandon, Nair, G., Urs Hess, Antonia Müller, Chalandon, Y., Nicoloso de Faveri, G., Duchosal, Michel A, Müller, Antonia, Masouridi Levrat, Stavroula, Ansari Djaberi, Marc Georges, Masouridi-Levrat, Stavroula, Heim, D., Müller, A., Halter, J.P., Baldomero, H., Masouridi-Levrat, S., Gabriela M. Baerlocher, Bargetzi, Mario, Stussi, Georg, Georg Stussi, Dominik Heim, Jörg P. Halter, Schanz, Urs, Marc Ansari, Michel A. Duchosal, Baerlocher, Gabriela M., Helen Baldomero, Ansari, Marc, Güngör, T., Halter, Jörg P, Nicoloso de Faveri, Grazia, Baerlocher, G.M., Gayathri Nair, Schmidt, A., Pabst, T., Urs Schanz, Stussi, G., Gerull, Sabine, Güngör, Tayfun, Stavroula Masouridi-Levrat, Mario Bargetzi, for the Swiss Blood Stem Cell Transplantation Group (SBST), Baldomero, Helen, Heim, Dominik, Hess, U., Hess, Urs, Gerull S, Schmidt A, Baerlocher GM, Renner C, Hess U, Güngör T, Ansari M, Passweg JR, Bargetzi M, Halter JP, Nair G, Baldomero H, Nicoloso de Faveri G, Masouridi-Levrat S, Müller A, Pabst T, Stussi G, For The Swiss Blood Stem Cell Transplantation Group Sbst, Schanz U, Duchosal MA, Heim D, Chalandon Y, Leibundgut K   +94 more
core   +2 more sources

Therapeutic choices in patients with Ph-Positive chronic myelogenous leukemia in Mexico in the era of tyrosine kinase inhibitors: stem cell transplantation or tyrosine kinase inhibitors? Fifteen years later

Revista de Investigación Clínica
Background: Chronic myelogenous leukemia is a neoplastic proliferation of the granulocytic series. In Mexico, chronic myelogenous leukemia accounts for approximately 10% of all leukemias.
Max Robles-Nasta, Daniela Sánchez-Bonilla, Moises M. Gallardo-Pérez, Edgar J. Hernández-Flores, Merittzel A. Montes-Robles, María de L. Pastelín-Martínez, Juan C. Olivares-Gazca, Guillermo J. Ruiz-Delgado, Guillermo J. Ruiz-Argüelles   +8 more
doaj   +1 more source

Acellular allogeneic nerve grafting combined with bone marrow mesenchymal stem cell transplantation for the repair of long-segment sciatic nerve defects: biomechanics and validation of mathematical models

Neural Regeneration Research, 2016
We hypothesized that a chemically extracted acellular allogeneic nerve graft used in combination with bone marrow mesenchymal stem cell transplantation would be an effective treatment for long-segment sciatic nerve defects.
Ya-jun Li, Bao-lin Zhao, Hao-ze Lv, Zhi-gang Qin, Min Luo   +4 more
doaj   +1 more source

CD4+CD25+FOXP3+ T regulatory cells reconstitute and accumulate in the bone marrow of patients with multiple myeloma following allogeneic stem cell transplantation

Haematologica, 2008
Background Very little is known about the number and function of immunosuppressive CD4+CD25+FOXP3+ T regulatory cells (Treg) in the human bone marrow and it is unclear whether bone marrow-residing Treg are capable of regenerating following allogeneic ...
Djordje Atanackovic, Yanran Cao, Tim Luetkens, Jens Panse, Christiane Faltz, Julia Arfsten, Katrin Bartels, Christine Wolschke, Thomas Eiermann, Axel R. Zander, Boris Fehse, Carsten Bokemeyer, Nicolaus Kroger   +12 more
doaj   +1 more source

Evading the Immune System: Immune Modulation and Immune Matching in Cell Replacement Therapies for Parkinson’s Disease

Journal of Parkinson’s Disease, 2021
Stem cell-based therapies for Parkinson’s disease are now being applied clinically. Notably, studies have shown that controlling the graft-induced immune response improves the results.
Asuka Morizane, Jun Takahashi
doaj   +1 more source

Allogeneic stem cell transplantation for thalassemia major

Haematologica, 2008
Allogeneic hemopoietic stem cell (HSC) transplantation in thalassemia major has been a cornerstone of the development of cell-based therapies[1][1] and a matter of passionate debate during the ‘80s and early ‘90s.[2][2] The aim of HSC transplantation in thalassemia is to replace the ...
Emanuele Angelucci, Donatella Baronciani
openaire   +3 more sources

Donation and transplantation of allogeneic hematopoietic stem cells [PDF]

Canadian Medical Association Journal, 2011
Only 30% of patients with indications for a transplant have a matched related donor; the remaining 70% seek an unrelated donor on the world’s registry. Nonwhite Canadians have a particularly low likelihood of finding a match.1,2 Appendix 1 lists common indications for transplant (available at ...
Ilana, Kopolovic, Robert, Turner
openaire   +2 more sources

Haematopoietic stem cell transplantation: activity in Switzerland compared with surrounding European countries [PDF]

, 2013
Haematopoietic stem cell transplantation (HSCT) is a highly specialised procedure used to treat malignancies of the lymphohaematopoietic system as well as some acquired and inherited disorders of the blood.
Gratwohl, A, Bargetzi, Mario, Stussi, Georg, Renner, Christoph, Güngör, T, Bucher, Christoph, Chalandon, Yves, Ozsahin, Hulya, Leibundgut, Kurt, Gratwohl, Alois, Schanz, Urs, Leibundgut, K, Stussi, G, Ozsahin, Ayse Hulya, Baldomero, H, Pabst, T, Chalandon, Y, Schanz, U, Passweg, Jakob R, Ozsahin, H, Passweg, Jakob, Pabst, Thomas, Passweg, J R, Hess, U, Renner, C, Duchosal, M A, SBST (Swiss Blood Stem Cell Transplantation Group),, Bargetzi, M, Duchosal, Michel A, Stern, Martin, de Faveri, Grazia Nicoloso, Güngör, Tayfun, de Faveri, G N, Bucher, C, Baldomero, Helen, Hess, Urs, Stern, M, Bargetzi, M., Passweg, J.R., Bucher, C., Leibundgut, K., Renner C, Duchosal, M.A., Stern, M., Hess U, Renner, C., Güngör T, Schanz, U., Gratwohl A, Passweg JR, Bargetzi M, Chalandon, Y., Gratwohl, A., Stern M, Bucher C, Ozsahin H, Baldomero, H., de Faveri, G.N., de Faveri GN, Baldomero H, Ozsahin, H., Pabst T, Güngör, T., Stussi G, Schanz U, Pabst, T., Stussi, G., Duchosal MA, Hess, U., Chalandon Y, Leibundgut K   +70 more
core   +1 more source

Allogeneic Stem Cell Transplantation for Aplastic Anemia

Biology of Blood and Marrow Transplantation, 2007
Aplastic anemia encompasses a heterogeneous group of diseases with distinct pathophysiologies and a common clinical endpoint of marrow failure. Patients with severe aplastic anemia can be treated with immunosuppressive therapy (IST) or hematopoietic stem cell transplantation (HSCT).
Armand, Philippe, Antin, Joseph H.
openaire   +2 more sources